back

MIT scientists debut a generative AI model that could create molecules addressing hard-to-treat diseases

Source

MIT News | Massachusetts Institute of Technology

Published

Nov 26, 2025

Share On

Get SIGNAL/NOISE in your inbox daily

A new model known as BoltzGen designs protein binders for any biological target from scratch. Developed at MIT, BoltzGen has shown promise for hard-to-treat targets in cancer and neurodegenerative diseases.

MIT scientists debut a generative AI model that could create molecules addressing hard-to-treat diseases

Recent Stories

Claude’s latest upgrade is the AI breakthrough I’ve been waiting for — 5 ways Cowork could be the biggest AI innovation of 2026

Signal’s founder is taking on ChatGPT — here’s why the ‘truly private AI’ can’t leak your chats

RoboSense robotics lidar sales surged 1,141.8% year on year